Hantz Financial Services, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Hantz Financial Services, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$0.28 - $1.16 $56 - $231	200 New	200 $0
Q1 2024 Aug 06, 2024	BUY	$1.06 - $1.67 $62 - $98	59 Added 15.05%	451 $1,000
Q4 2023 Aug 06, 2024	BUY	$1.26 - $1.79 $15 - $21	12 Added 3.16%	392 $1,000
Q3 2023 Aug 06, 2024	SELL	$1.61 - $2.54 $24 - $38	-15 Reduced 3.8%	380 $1,000
Q1 2023 Aug 06, 2024	BUY	$1.2 - $2.19 $4 - $8	4 Added 1.02%	395 $1,000
Q4 2022 Aug 06, 2024	BUY	$1.63 - $3.52 $326 - $704	200 Added 104.71%	391 $1,000
Q3 2022 Aug 06, 2024	SELL	$0.73 - $3.74 $6 - $33	-9 Reduced 4.5%	191 $1,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.